Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Finerenone Pediatric Suspension vs Adult Tablet
NCT02957396Phase 1Completed
- Sponsor
- Bayer
- Start
- Nov 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of finerenone in chronic kidney disease (CKD) and diabetic kidney disease (DKD) (4 arms), sponsored by Bayer. Primary endpoints: Area Under the Plasma Concentration vs. Time Curve, Maximum Plasma Concentration and 2 more. Started Nov 2016; status: completed.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT02957396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957396.